WASHINGTON, Nov. 2, CMC – The Pan American Health Organization (PAHO) says starting in the first quarter of 2025, through its Regional Revolving Funds, that it will provide countries of the Americas, including the Caribbean, with affordable access to the vaccine against respiratory syncytial virus (RSV), a leading cause of pediatric hospitalization and death from respiratory infections during the first six months of life.
You have read your free article
Create a free account to keep reading. Two articles each month, plus the daily CANANews newsletter.
CANANews is the Caribbean’s regional wire. Your subscription supports independent newsroom coverage from across the region.
